Optimizing the use of docetaxel in men with castration-resistant metastatic prostate cancer. [electronic resource]
Producer: 20100809Description: 108-16 p. digitalISSN:- 1476-5608
- Androgen Antagonists -- therapeutic use
- Antineoplastic Agents -- administration & dosage
- Clinical Trials as Topic
- Docetaxel
- Drug Administration Schedule
- Humans
- Male
- Neoplasm Metastasis -- prevention & control
- Orchiectomy
- Prednisone -- therapeutic use
- Prognosis
- Prostatic Neoplasms -- drug therapy
- Substance Withdrawal Syndrome
- Taxoids -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.